Kyverna Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.About KYTX
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
CEOWarner Biddle
CEOWarner Biddle
Employees112
Employees112
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2018
Founded2018
Employees112
Employees112
KYTX Key Statistics
Market cap302.63M
Market cap302.63M
Price-Earnings ratio-2.75
Price-Earnings ratio-2.75
Dividend yield—
Dividend yield—
Average volume2.53M
Average volume2.53M
High today$9.00
High today$9.00
Low today$6.72
Low today$6.72
Open price$6.94
Open price$6.94
Volume15.58M
Volume15.58M
52 Week high$13.67
52 Week high$13.67
52 Week low$1.78
52 Week low$1.78
Stock Snapshot
As of today, Kyverna Therapeutics, Inc.(KYTX) shares are valued at $7.19. The company's market cap stands at 302.63M, with a P/E ratio of -2.75.
On 2025-12-17, Kyverna Therapeutics, Inc.(KYTX) stock traded between a low of $6.72 and a high of $9.00. Shares are currently priced at $7.19, which is +7.0% above the low and -20.1% below the high.
The Kyverna Therapeutics, Inc.(KYTX)'s current trading volume is 15.58M, compared to an average daily volume of 2.53M.
In the last year, Kyverna Therapeutics, Inc.(KYTX) shares hit a 52-week high of $13.67 and a 52-week low of $1.78.
In the last year, Kyverna Therapeutics, Inc.(KYTX) shares hit a 52-week high of $13.67 and a 52-week low of $1.78.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KYTX. This list is generated using Robinhood data, and it’s not a recommendation.